• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前驱期、早期和中度帕金森病患者黑质体积损失情况

Nigral volume loss in prodromal, early, and moderate Parkinson's disease.

作者信息

Langley Jason, Hwang Kristy S, Huddleston Daniel E, Hu Xiaoping P

机构信息

Center for Advanced Neuroimaging, University of California, Riverside, CA, USA.

Section of Neurology, Department of Medicine, VA Long Beach Healthcare System, Long Beach, CA, USA.

出版信息

NPJ Parkinsons Dis. 2025 Jun 21;11(1):181. doi: 10.1038/s41531-025-00976-3.

DOI:10.1038/s41531-025-00976-3
PMID:40544165
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12182591/
Abstract

The loss of melanized neurons in the substantia nigra pars compacta (SNc) is a hallmark pathology in Parkinson's disease (PD). Melanized neurons in SNc can be visualized in vivo using magnetization transfer (MT) effects. Nigral volume was extracted in data acquired with a MT-prepared gradient echo sequence in 50 controls, 90 non-manifest carriers (46 LRRK2 and 44 GBA1 nonmanifest carriers), 217 prodromal hyposmic participants, 76 participants with rapid eye movement sleep behavior disorder (RBD), 194 de novo PD patients and 26 moderate PD patients from the Parkinson's Progressive Markers Initiative. No difference in nigral volume was seen between controls and LRRK2 and GBA1 non-manifest carriers (F = 0.732; P = 0.483). A significant main effect in group was observed between controls, prodromal hyposmic participants, RBD participants, and overt PD patients (F = 9.882; P < 10). This study shows that nigral depigmentation can be robustly detected in prodromal and overt PD populations.

摘要

黑质致密部(SNc)中黑色素化神经元的丧失是帕金森病(PD)的标志性病理特征。SNc中的黑色素化神经元可通过磁化传递(MT)效应在体内可视化。在帕金森病进展标志物倡议项目中,从50名对照者、90名未出现症状的携带者(46名LRRK2和44名GBA1未出现症状的携带者)、217名前驱性嗅觉减退参与者、76名快速眼动睡眠行为障碍(RBD)参与者、194名新发PD患者和26名中度PD患者中,使用MT准备的梯度回波序列采集的数据中提取黑质体积。对照者与LRRK2和GBA1未出现症状的携带者之间的黑质体积未见差异(F = 0.732;P = 0.483)。在对照者、前驱性嗅觉减退参与者、RBD参与者和明显的PD患者之间观察到显著的组间主效应(F = 9.882;P < 10)。这项研究表明,在前驱性和明显的PD人群中可以可靠地检测到黑质色素脱失。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd87/12182591/c8d9df814a1b/41531_2025_976_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd87/12182591/fcf31c2e5457/41531_2025_976_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd87/12182591/663957d83135/41531_2025_976_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd87/12182591/e3f36f43a650/41531_2025_976_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd87/12182591/134d90a93d3a/41531_2025_976_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd87/12182591/c8d9df814a1b/41531_2025_976_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd87/12182591/fcf31c2e5457/41531_2025_976_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd87/12182591/663957d83135/41531_2025_976_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd87/12182591/e3f36f43a650/41531_2025_976_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd87/12182591/134d90a93d3a/41531_2025_976_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd87/12182591/c8d9df814a1b/41531_2025_976_Fig5_HTML.jpg

相似文献

1
Nigral volume loss in prodromal, early, and moderate Parkinson's disease.前驱期、早期和中度帕金森病患者黑质体积损失情况
NPJ Parkinsons Dis. 2025 Jun 21;11(1):181. doi: 10.1038/s41531-025-00976-3.
2
Nigral volume loss in prodromal, early, and moderate Parkinson's disease.前驱期、早期和中度帕金森病患者黑质体积减少
medRxiv. 2025 Mar 21:2023.08.19.23294281. doi: 10.1101/2023.08.19.23294281.
3
an adaptive immune response gene, is associated with Parkinson's disease risk and age at onset.一种适应性免疫反应基因,与帕金森病风险及发病年龄相关。
J Parkinsons Dis. 2024 Nov;14(8):1575-1583. doi: 10.1177/1877718X241296015. Epub 2024 Dec 1.
4
Prodromal Parkinsonian Features in Carriers of Gaucher Disease Compared to Controls.与对照组相比,戈谢病携带者的帕金森病前驱特征
Life (Basel). 2025 Jun 13;15(6):952. doi: 10.3390/life15060952.
5
Subthalamic and nigral stimulation for freezing of gait in Parkinson's disease: Randomized pilot trial.丘脑底核和黑质刺激治疗帕金森病步态冻结:随机试点试验。
J Parkinsons Dis. 2024 Nov;14(8):1602-1613. doi: 10.1177/1877718X241292315. Epub 2025 Jan 17.
6
Prodromal depression and subsequent risk of developing Parkinson's disease: a systematic review with meta-analysis.前驱期抑郁与随后发生帕金森病的风险:系统评价与荟萃分析。
Neurodegener Dis Manag. 2022 Jun;12(3):155-164. doi: 10.2217/nmt-2022-0001. Epub 2022 May 5.
7
Tissue Factor and Its Cerebrospinal Fluid Protein Profiles in Parkinson's Disease.组织因子及其在帕金森病中的脑脊液蛋白谱。
J Parkinsons Dis. 2024;14(7):1405-1416. doi: 10.3233/JPD-240115.
8
A minimally Invasive Biomarker for Sensitive and Accurate Diagnosis of Parkinson's Disease.一种用于帕金森病灵敏且准确诊断的微创生物标志物。
medRxiv. 2024 Jun 30:2024.06.29.24309703. doi: 10.1101/2024.06.29.24309703.
9
Alterations of fecal microbiota and plasma metabolome in patients with Parkinson's disease with rapid eye movement sleep disorder.伴有快速眼动睡眠障碍的帕金森病患者粪便微生物群和血浆代谢组的改变
mSphere. 2025 Jun 25;10(6):e0059024. doi: 10.1128/msphere.00590-24. Epub 2025 May 9.
10
Use of β-adrenoreceptor drugs and Parkinson's disease incidence in women from the French E3N cohort study.来自法国E3N队列研究的女性中β-肾上腺素能受体药物的使用与帕金森病发病率
J Parkinsons Dis. 2025 Apr 29:1877718X251330993. doi: 10.1177/1877718X251330993.

本文引用的文献

1
In vivo detection of substantia nigra and locus coeruleus volume loss in Parkinson's disease using neuromelanin-sensitive MRI: Replication in two cohorts.使用神经黑色素敏感 MRI 检测帕金森病中黑质和蓝斑体积的损失:在两个队列中的复制研究。
PLoS One. 2023 Apr 13;18(4):e0282684. doi: 10.1371/journal.pone.0282684. eCollection 2023.
2
Baseline characteristics of the North American prodromal Synucleinopathy cohort.北美前驱性神经核蛋白病队列的基线特征。
Ann Clin Transl Neurol. 2023 Apr;10(4):520-535. doi: 10.1002/acn3.51738. Epub 2023 Feb 8.
3
Nigral volumetric and microstructural measures in individuals with scans without evidence of dopaminergic deficit.
对扫描时无多巴胺能缺乏证据的个体进行黑质体积和微观结构测量。
Front Neurosci. 2022 Nov 24;16:1048945. doi: 10.3389/fnins.2022.1048945. eCollection 2022.
4
Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort.PPMI队列中未表现出症状的LRRK2 G2019S携带者的纵向临床和生物标志物特征。
NPJ Parkinsons Dis. 2022 Oct 22;8(1):140. doi: 10.1038/s41531-022-00404-w.
5
Neuromelanin and T*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson's disease.神经黑色素与T*磁共振成像用于评估遗传易患、前驱期及有症状的帕金森病。
NPJ Parkinsons Dis. 2022 Oct 21;8(1):139. doi: 10.1038/s41531-022-00405-9.
6
Serial olfactory testing for the diagnosis of prodromal Parkinson's disease in the PARS study.在 PARS 研究中,进行连续嗅觉测试以诊断前驱期帕金森病。
Parkinsonism Relat Disord. 2022 Nov;104:15-20. doi: 10.1016/j.parkreldis.2022.09.007. Epub 2022 Sep 17.
7
Deep Learning-Based Neuromelanin MRI Changes of Isolated REM Sleep Behavior Disorder.基于深度学习的孤立性快速眼动睡眠行为障碍的神经黑色素 MRI 变化。
Mov Disord. 2022 May;37(5):1064-1069. doi: 10.1002/mds.28933. Epub 2022 Feb 1.
8
Imaging of the nigrostriatal system for evaluating the preclinical phase of Parkinson's disease development: the utility of neuromelanin, diffusion MRI, and DAT-SPECT.评估帕金森病发展临床前期的黑质纹状体系统影像学:神经黑色素、弥散 MRI 和 DAT-SPECT 的效用。
Br J Radiol. 2022 Feb 1;95(1130):20210837. doi: 10.1259/bjr.20210837. Epub 2021 Nov 26.
9
Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder.孤立性快速眼动睡眠行为障碍向α-突触核蛋白病转化的生物标志物。
Lancet Neurol. 2021 Aug;20(8):671-684. doi: 10.1016/S1474-4422(21)00176-9.
10
The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson's disease.帕金森病中多巴胺、神经黑色素和铁的时空变化。
Brain. 2021 Nov 29;144(10):3114-3125. doi: 10.1093/brain/awab191.